drugset

drugset / Trial / NCT01008163

A Dose-Finding, Efficacy and Safety Study of YY-351 in Patients With Type 2 Diabetes

NCT01008163 ↗

Phase 2 Completed 72 enrolled Yuyu Pharma, Inc.

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this trial is to determine the dosage selected and to evaluate the efficacy and safety of YY-351.

Timeline

Start: 2008-01
Primary completion: 2009-06
Completion: 2009-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	YY-351	Unknown	—	Oral

Indications